Juvenile-HD

HOME

INDEX Page
Tools For Viewing
10 The Most Commonly Asked Questions
Clinical Trials & Research
Huntington's Disease~WeMove Info
Advocacy/Donations/Press Info
Clinical Definition & Search
Facing HD~Family Handbook
JHD Handbook-Chapter 1
JHD Info-Stanford Univ.
Physician's Guide To HD
Caring for People with HD
Physical & Occupational Therapy In HD
Understanding Behaviour in HD-Dr. Jane Paulsen
Understanding Behavioral-Dr. Edmond Chiu
Advanced Stages Caregivers Handbook
First Shift-Certified Nursing Assistants
Activities of Daily Living-HD
Unified HD Rating Scale (UHDRS) Motor Section
Westphal Variant
SECTION 1 - AT RISK
Age & Probability Chart
At Risk For HD-What Next?
At-Risk Checklist
Best Interest of Child?
Crystal Ball?
Food For Thought
Parent Hasn't Tested?
Q&A On Risk of Inheriting JHD
Testing Children
SECTION 2 - GENETIC TESTING
Genetic Disorders & Birth Defects
Genetic Testing for HD
Genetic Counseling-In General
Psychological Impact
Intro: Genetics/Genetic Testing
Prenatal & Preimplanation
Prenatal Testing-In General
o Genetic Testing Resources
o Personal Stories
SECTION 3 - JHD
Coping With The Early Years
Age of HD Appearance
Age of Onset-Historical
Family-HD Underestimated
Children of Parents With HD
Child~Parent Ill
Clinical Description JHD
HD - What Kids Are Saying
HD & Me
JHD-Duration of Illness
JHD-Clinical and Research
JHD Symptoms
Parenting With HD
Patients/Families Coping
Talking With Children About HD
5 Stages of HD
JHD Resources
SECTION 4 - SYMPTOM RECOGNITION
Parent Resources
8 Fears of A Chronic Illness
Anxiety/Apathy/Irritability~HD
Anxiety, Fears & Phobias
Apathy-Physician's Guide
Ataxia
Attention-Perceptual/Unawareness Physician's Guide
Bed/Pressure Sores
Bed/Pressure Ulcer Guideline
Behavior Management
Bi-Polar Disorders
Botulinum toxin therapy
Bradykinesia
Caring Tips
Child Abuse-Reconizing Signs
Chorea-Physician's Guide
Chorea
Cognitive/Decision Making/Impulsivity
Cognitive-Short Tips
Contractures~Joints Locking
Dehydration-Physician's Guide
Dehydration
Delirium
Denial of HD
Depression~Physician's Guide
Depression-Understanding It
Depression-How To Help
Depression - Treatment Resistant Patient
Depression-Other Resources
-Read If Your Child Is On Antidepressant
Disgust - Impaired Recognition in HD
Dissociative disorders
Driving - Physician's Guide
Dyslexia
Dyslexia Resources
Dystonia
Dystonia/Rigidity & Spasticity Physician's Guide
Dystonia-Predominant Adult-Onset HD
Epileptic Seizures and Epilepsy
Epilepsy-Seizures~PG
-Seizures ~Special Populations
Falling~Safety
Falling - Subdural Hematoma Risk
Fevers - Unexplained
Fevers, sweating & menstural cycles in HD
GERD (Stomach)
HD Principle Treatments
Hallucinations/Psychosis~PGHD
Hand muscle reflexes in HD
Hypothalamus - A Personal Theory
Insomia ~Physician's Guide
Irritability~Temper Outburst Physician's Guide
Learning Disability
Mania/OCD~Physician's Guide
Mood Disorder Rate In HD
Myoclonus (Movements)
Nails-What To Look For
Night Terrors
Obsessive Compulsive OCD
Panic Disorder
Personality disorders
Pneumonia
Pneumonia-Advanced Stages
Pneumonia - Aspirated (Inhaled)
Prosody - Social Impairment
Sexuality~Physician's Guide
Skins Sensitivity
Sleep Disorders
Smoking-Physician's Guide
Spasticity
Stress
Tremors
Why Certain Symptoms Occur
Symptom & Treatment Resources
SECTION 5 - COMMUNICATION
Communication Resources
Communication Problems
Communication Strategies For HD~Jeff Searle
SECTION 6 - EATING/SWALLOWING/NUITRITION
Hints For Weight Loss in HD
HD & Diet~HSA Fact Sheet 7
Nutrients: Some Possible Deficiency Symptoms
Nutrition and HD~Anna Gaba (Recipes)
Nutrition Information In HD~Naomi Lundeen
Speech & Swallowing~Lynn Rhodes
Swallowing & Nutrition Physician's Guide To HD
Swallowing & Nuitrition Resources
Swallowing Warning Signs
5 Swallowing Problems
Taste changes in HD
Weight Gain
Resources-Drinks/Shakes
-Feeding Tubes~Advanced Stages of HD
-Feeding Tube~Jean Miller
-Feeding Tubes: One More Word ~Jean Miller
-Feeding Tubes & Baby Foods
-Feeding Tube~Dental Care
-Feeding Tube Instructions~Jean Miller
-Feeding Tube Resources
SECTION 7 - THERAPIES
Finding a Therapist - Behavoir
What Is A Physiotherapist?
Physical Therapy In HD
Speech-Language Therapy
Therapy Descriptions
Therapy Resources- Easter Seal
Therapy Resources
SECTION 8 - MEDICATIONS
HD Treatments
Medications-Movement Disorders
Medication/Emergency Info Forms
Cutting Prescriptions
Drugs-Look 'Em Up
-Adolescents Under 25
-Antidepressant Adverse Effects
-Anti-psychotic
-Anxiety-Antidepressant
A-Z Mental Health Drugs
-Creatine
-EPA~Fish Oil
-Haldol/Haloperidol - Clinical Sheet
-Haldol~Clinician Description
-Haldol & HD
-Haldol/HD Patient Experiences
-Haldol~ Patient Handout
-Mood Stabilizers: ASK 3 Questions
-Neuroleptic Malignant Synd WARNING
-Olanzipine-Risperidone/blood tests
-Celexa/Luvox/Paxil/Prozac/Zoloft
-Psychiatric Drugs & Children
Sertraline ~Zoloft
-Spasticity Meds/Treatments
-SSRI Medications
-Tardive Dyskinesia WARNING
-Weight Gain Medications
-Sites/Help the Medicine Go Down
-Vitamin & Mineral Deficiencies
SECTION 9 - SURGERIES
Surgery-Movement Disorders
o Surgery Resources
SECTION 10 - PROCEDURES
Clinic Visits-How To Prepare
CT Scans, MRI's etc.
Swallowing Tests
Tests Commonly Used
o Procedures Resources
SECTION 11- ALCOHOL/DRUGS
Alcohol-Parent's Guide
Alcohol-Talking To Your Child
Drugs-What To Do?
Drugs-Talking To Your Child
Disciplining-Ages 0-13 & Up
SECTION 12- SUICIDE
Straight Talk On Suicide
Teen Suicide-You Need To Know
o Suicide Resources
SECTION 13 - DIVORCE
Divorce & Child Stress
Tips For Divorcing Parents
SECTION 14 - DISABILITY ISSUES
Guides To Disability Issues
Caring-Child & Medical Technology
Caring for a Seriously Ill Child
Child Long Term Illness
Disability-Special Education Plan
IFSP Early Intervention Process
Disability Resources
Financial Planning
Wishes Can Come True-Children's Wish Foundations
Special Needs Resources
Special Needs Camp - About
Special Needs Camp - Finding One
SECTION 15 - ASSISTIVE TECHNOLOGY
Child Assistive Technology
Adaptive Equipment Resources
Products
SECTION 16 - EMOTIONAL ISSUES
Signs of Unhealthy Self-Esteem
Emotional Behavior Links
o Emotional Support Resources
SECTION 17 - GRIEF
Helping Child Deal With Death
o Grief Addtional Resources
SECTION 18 - ADD/ADHD
ADD & Teens
Conduct Disorders
FAQS & Related Info
Understanding AD/HD
What Is AD/HD?
Research Articles
Resources
SECTION 19 - HD SUPPORT GROUPS
HD Support Groups
National Youth Association
SECTION 20 - HD LINKS
HD Links
Related Resources
Tips For Friends
SECTION 21 - BENEFITS/INSURNACE
HD Disability
Benefits Check UP - See What You Can Get
Medical Insurance Bureau's Facts On You!
Medicare-Medicaid
Medicare Rights-Home Health & Hospice
Medicare Rights Center Resources
No Insurance? Try This!
Prescription Drug Cards Part I
Prescription Drug Cards Part II
Social Security-Children With Disabilities
SECTION 22 - ARTICLES/JHD
JHD and ADD
SECTION 23 - CAREGIVING
Articles-Resources
Caregiver Self-Assessment
Caregiver's Handbook
"First Shift With A Person With HD"
Getting Respite Care/Help At Home
Helpful Forms-Info
Home Emergency Preparations
Symptom Management
Ten Tips
Useful Tools
SECTION 24 - BIO
Our Personal Experience
Coping At The End
Kelly E. Miller
Song & Verse
Letter From My Heart
GUESTBOOK
-Neuroleptic Malignant Synd WARNING

INDEX Page

Drug Induced Movement Disorders


NEUROLEPTIC MALIGNANT SYNDROME

Clinical

Neuroleptic malignant syndrome is the rarest of the neuroleptic induced movement disorders. It is the most serious and represents a neurologic emergency in most cases. It has now been reported to occur with all drugs  that effect the central dopaminergic system (including dopamine agonists and levodopa).

There's an isolated report of neuroleptic malignant syndrome in a patient on a trycyclic medication. It is likely an idiosyncratic reaction and  patients can, if needed, be given the same agent again without recurrence.

It is estimated that 0.5-1% of patients exposed to neuroleptics will develop  this syndrome. Most patients will develop it shortly after initial exposure and 90% within two weeks of starting the neuroleptic. It can occur with all the neuroleptics but haldol and trifluperazine are the most common. It has also  been seen with clozapine and metoclopramide.

The classic triad involves the autonomic nervous system (fever in 100%), the extrapyramidal system (rigidity), and cognitive changes.

The two  characteristic laboratory findings reported in 75% of cases are a high CPK and leukocytosis. 95% of patients are iron deficient. The CSF is usually normal. The EEG can show diffuse slowing. Other features include tachypnea (78%),  diaphoresis (60%), and labile blood pressure (54%).

The temperature does not usually exceed 41°C and often peaks before the motor systems become  prominent. The most frequent extrapyramidal findings include rigidity (90%) and tremor (56%).

Dystonia and chorea have also been reported. Mental status changes occur in 75% of patients. This starts as drowsiness and  confusion but can progress to stupor and coma. Other symptoms can include seizures, pyramidal tract findings, ocular flutter, cardiac arrhythmias.

Physical exhaustion, dehydration, hyponatremia, young male gender, affective  disorders, thyrotoxicosis, or prior brain pathology all increase the rate of this syndrome developing. An increased risk occurs in patients combining haldol with lithium.

Once symptoms develop progression is quite rapid and reaches peak intensity in about 72 hours. This can very from 45 minutes to as long as 65 days. Some cases remain mild and clear up without intervention.

The duration  of the symptoms can last from 8 hours to 40 days (longer with parental medication). With early recognition and aggressive treatment there is only a 5% mortality rate (much improved in the last 20 years).

Most patients who  survive make a full recovery. Some are left with permanent parkinsonism, ataxia, and dementia. Re-occurrences have been described following exposure to the same neuroleptic but this is not common.

Pathophysiology

The pathophysiology is not completely understood but is thought to involve 3 systems.

These include abnormalities in the:

  1. Central dopamine system.
  2. Muscle membrane dysfunction.
  3. Sympathetic nervous system. Evidence for the central dopamine mechanism comes from the  fact that a similar syndrome is seen in Parkinson's disease with abrupt withdrawal of  levodopa or  anticholinergics. Additionally 95% of patients with this syndrome develop  parkinsonian symptoms. Muscle abnormalities have been invoked because of the clinical  similarity to malignant hyperthermia.  Abnormalities in the sympathetic system are  supported by changes in the urine and plasma catecholamine levels.

Treatment

Early recognition is extremely important to reduce mortality. Without therapy this syndrome will resolve on its own over several weeks but with  active treatment improvement will occur within 48-72 hours.

The first phase of treatment is supportive therapy with adequate hydration and metabolite (electrolyte) stabilization with cooling blankets to reduce  hyperthermia. Ventilatory assistance may be required and occasionally dialysis is necessary for renal dysfunction.

Drug therapy starts with discontinuing the neuroleptic. There are a variety of  other effective medications that can be used but the two most frequent ones include Dantrolene sodium and bromocriptine (individually or combined). These drugs reduce the mortality and shorten the course of the syndrome.  Dantrolene can be given intravenously or orally starting with 2-3 mg per kg doses divided TID up to a total of 10 mg/kg/day. Bromocriptine can be given orally or by NG tube starting with 2.5 mg TID and increasing every 24 hours  by 2.5 mg TID until a response is seen or until a maximum dose of 60 mg is achieved.

It is reasonable to start both drugs at the same time with intravenous Dantrolene and oral bromocriptine. Once symptoms start to resolve the  Dantrolene can be discontinued and the bromocriptine can be maintained. The duration of treatment should be at least for ten days for oral neuroleptics, and two to three weeks for parental drugs. Other treatments that can be used  include levodopa, pergolide, benzodiazepines, and rarely ECT.

If this syndrome occurs in the setting of Parkinson's disease the treatment is basically the same except the parkinsonian medication should be re-instituted  as quickly as possible. Because of the risk of this syndrome drug holidays are no longer routinely recommended for Parkinson's disease.

If the neuroleptic is to be reintroduced a waiting period of two weeks should  be used for oral medication at least six weeks for parental medication. It would be prudent to use a different neuroleptic than the one that originally caused the syndrome.

http://www.cmdg.org/Movement

=================================================

What Is Antipsychotic Medication?

Antipsychotic medication, otherwise known as neuroleptics, are mainly used in the treatment of disorders where there is an element of psychosis.

How Do They Work?

Antipsychotics can be split into two types; typical antipsychotics and atypical antipsychotics.

Both types work by altering the level of chemicals (called neurotransmitters) in the brain. These chemicals are the ones that are involved in transmitting impulses down the nerves in the brain. They tend to work at junctions between nerve fibres (called synapses). At these junctions the level of neurotransmitters is crucial in deciding whether an impulse carries on, or is stopped.

It is thought that in psychosis, the balance of neurotransmitters in the brain is wrong.

The particular name of the neurotransmitter that is affected by typical antipsychotics is dopamine. Atypical antipsychotics affect both dopamine and other neurotransmitters such as serotonin.

What Are The Possible Side-Effects?

Side-effects will be discussed as we consider each specific drug.

The Antipsychotics Available

Medicines tend to have more than one name. They have a general name (called the non-proprietary name), and a name given to them by the drug company that makes them (called the proprietary name). This can be very confusing, so we will list the antipsychotics by writing the non-proprietary name first, followed by the propriatary names in brackets. Just Click on the antipsychotic that interests you.

Typical Antipsychotics

  • Chlorpromazine (Largactil)
  • Droperidol (Droleptan, Thalamonal)
  • Flupenthixol (Depixol, Fluanxol)
  • Fluphenazine (Modecate, Moditen, Motipress, Motival)
  • Haloperidol (Haldol, Serenace)
  • Thioridazine (Melleril)
  • Trifluoperazine (Stelazine, Parstelin)
  • Zuclopenthixol (Clopixol)
  • Atypical Antipsychotics

  • Clozapine (Clozaril)
  • Olanzapine
  • Risperidone